⚕ GalenOps CRO console
← 708 (USA)

708-1178

withdrawn
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 708 (USA) (Dr. Kim) · consented 2013-12-29
Adverse events
9
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild ALCOHOL USE — outcome: RECOVERED/RESOLVED; onset 2014-03-24 (study day 86.0); relationship: NONE

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-09 (study day 71.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: RECOVERED/RESOLVED; onset 2014-03-09 (study day 71.0); relationship: PROBABLE

severe assessed 2026-08-18

Severe ATRIAL FIBRILLATION — outcome: RECOVERED/RESOLVED; onset 2014-03-24 (study day 86.0); relationship: POSSIBLE; serious criteria: hospitalization

mild assessed 2026-08-18

Mild CYSTITIS — outcome: RECOVERED/RESOLVED; onset 2014-03-24 (study day 86.0); relationship: REMOTE

severe assessed 2026-08-18

Severe DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2014-03-24 (study day 86.0); relationship: POSSIBLE; serious criteria: hospitalization

mild assessed 2026-08-18

Mild FLANK PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-19 (study day -10.0); relationship: NONE

mild assessed 2026-08-18

Mild NASOPHARYNGITIS — outcome: RECOVERED/RESOLVED; onset 2014-03-01 (study day 63.0); relationship: NONE

mild assessed 2026-08-18

Mild VENTRICULAR SEPTAL DEFECT — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-09 (study day 71.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.